✦ LIBER ✦

The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use

✍ Scribed by Michael Berk; Felicity Ng; Seetal Dodd; Tom Callaly; Shirley Campbell; Michelle Bernardo; Tom Trauer

Book ID: 108853285
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 93 KB
Volume: 14
Category: Article
ISSN: 1356-1294
DOI: 10.1111/j.1365-2753.2007.00921.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The validity of the 21-item version of t

The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure

✍ Felicity Ng; Tom Trauer; Seetal Dodd; Tom Callaly; Shirley Campbell; Michael Ber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 Dutch ⚖ 128 KB

Psychometric validity and clinical usefu

Psychometric validity and clinical usefulness of the Vineland Adaptive Behavior Scales and the AAMD Adaptive Behavior Scale for an autistic sample

✍ Adrienne Perry; David C. Factor 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 749 KB

Reliability, validity and clinical utili

Reliability, validity and clinical utility of a Japanese version of the Social Adaptation Self-evaluation Scale as calibrated using the Beck Depression Inventory

✍ Nobuhisa Ueda; Akira Suda; Makiko Nakagawa; Hideki Nakano; Wakako Umene-Nakano; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

The quality of spine surgery from the pa

The quality of spine surgery from the patient’s perspective: Part 2. Minimal clinically important difference for improvement and deterioration as measured with the Core Outcome Measures Index

✍ A. F. Mannion; F. Porchet; F. S. Kleinstück; F. Lattig; D. Jeszenszky; V. Bartan 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 214 KB

The Disease Activity Score is not suitab

The Disease Activity Score is not suitable as the sole criterion for initiation and evaluation of anti–tumor necrosis factor therapy in the clinic: Discordance between assessment measures and limitations in questionnaire use for regulatory purposes

✍ Frederick Wolfe; Kaleb Michaud; Theodore Pincus; Daniel Furst; Edward Keystone 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

## Abstract ## Objective The Disease Activity Score (DAS) is widely used in clinical trials. A DAS of 5.1 defines the level of severe rheumatoid arthritis (RA) and is the criterion for the initiation of anti–tumor necrosis factor therapy in the UK and The Netherlands. In North America, similar rul

DEVELOPMENT AND VALIDATION OF A COMPOSIT

DEVELOPMENT AND VALIDATION OF A COMPOSITE SCORE AS AN EASY-TO-USE INSTRUMENT FOR CLINICAL MONITORING OF DEMENTIA PROGRESSION: THE COMPOSITE COGNITIVE AND ACTIVITIES OF DAILY LIVING FUNCTIONING SCORE

✍ René J.F. Melis; Sara B. Angleman; Laura Fratiglioni 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB